Neesse, Albrecht <br/><br/>
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Jul 2013 
 - 12325-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1300415110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Connective Tissue Growth Factor--antagonists & inhibitors<br/>Deoxycytidine--administration & dosage<br/>Liver Neoplasms--secondary<br/>Mice<br/>Pancreatic Neoplasms--drug therapy<br/>Survival Analysis<br/>X-Linked Inhibitor of Apoptosis Protein--metabolism<br/>Gemcitabine